NCT00792649

Brief Summary

Colonoscopy is the accepted gold standard for screening of colorectal cancer. However, small and flat neoplastic lesions might be overlooked with standard video endoscopes. The new available EPKi system (Pentax, Japan) enables with HD+ imaging resolution above HDTV standard. Aim of the study was to test the efficacy of HD+ colonoscopy alone and in conjunction with I-Scan (newly developed post processing digital filter)in comparison to standard videoendoscopy

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 18, 2008

Completed
Last Updated

November 18, 2008

Status Verified

February 1, 2008

First QC Date

November 17, 2008

Last Update Submit

November 17, 2008

Conditions

Study Arms (2)

1

screening colonoscopy with HD+ endoscopes

2

screening colonoscopy with standardvideoendoscopes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients scheduled for screening colonoscopy were examined using HD+ colonosccopes and standardendoscopes.

You may qualify if:

  • Consecutive patients scheduled for screening colonoscopy

You may not qualify if:

  • Inflammatory bowel disease
  • Cancer
  • Pregnancy
  • Inability to obtain informed consent
  • Prothrombin time \< 50% of control
  • Partial thromboplastin time \> 50 seconds

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

PolypsNeoplasms

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 17, 2008

First Posted

November 18, 2008

Study Start

February 1, 2008

Last Updated

November 18, 2008

Record last verified: 2008-02